Evidence map›Paper›PMID 26500584›Full record

ReviewFrontiers in psychology2015

Neurotransmitters as food supplements: the effects of GABA on brain and behavior.

Evert Boonstra, Roy de Kleijn, Lorenza S Colzato, Anneke Alkemade, Birte U Forstmann, Sander Nieuwenhuis

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in psychology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05808101 (Role of the Gut Microbiome as Determinant of Depression in Multiple Sclerosis Subjects), which is not on this map. Cited by 142 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed, 1 pooled it
18.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05808101 terminatednot on this mapstarted 2022, after this paper: background citation

Role of the Gut Microbiome as Determinant of Depression in Multiple Sclerosis Subjects

TypeobservationalSponsorWashington University School of MedicineRan2022 to 2024Enrolled51ConditionsMultiple Sclerosis, DepressionArmsNeuro-QoL T-score determination
3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 1 synthesis or guideline pooled it, 332 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Isolation and Characterization ofJournal of microbiology and biotechnology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. GABA-Producing Capabilities ofJournal of microbiology and biotechnology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Efficacy of a NovelAnimals : an open access journal from MDPI · 2025
    Article
  19. Review
  20. Review

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Evert BoonstraCognitive Psychology Unit, Institute of Psychology, Leiden University , Leiden, Leiden ; Leiden Institute for Brain and Cognition, Leiden University , Leiden, Leiden.
Roy de KleijnCognitive Psychology Unit, Institute of Psychology, Leiden University , Leiden, Leiden ; Leiden Institute for Brain and Cognition, Leiden University , Leiden, Leiden.
Lorenza S ColzatoCognitive Psychology Unit, Institute of Psychology, Leiden University , Leiden, Leiden ; Leiden Institute for Brain and Cognition, Leiden University , Leiden, Leiden.
Anneke AlkemadeCognitive Science Center Amsterdam, University of Amsterdam , Amsterdam, Netherlands.
Birte U ForstmannCognitive Science Center Amsterdam, University of Amsterdam , Amsterdam, Netherlands ; Max Planck Institute for Human Cognitive and Brain Sciences , Leipzig, Germany.
Sander NieuwenhuisCognitive Psychology Unit, Institute of Psychology, Leiden University , Leiden, Leiden ; Leiden Institute for Brain and Cognition, Leiden University , Leiden, Leiden.
Leiden University · NLMax Planck Institute for Human Cognitive and Brain Sciences · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the human cortex. The food supplement version of GABA is widely available online. Although many consumers claim that they experience benefits from the use of these products, it is unclear whether these supplements confer benefits beyond a placebo effect. Currently, the mechanism of action behind these products is unknown. It has long been thought that GABA is unable to cross the blood-brain barrier (BBB), but the studies that have assessed this issue are often contradictory and range widely in their employed methods. Accordingly, future research needs to establish the effects of oral GABA administration on GABA levels in the human brain, for example using magnetic resonance spectroscopy. There is some evidence in favor of a calming effect of GABA food supplements, but most of this evidence was reported by researchers with a potential conflict of interest. We suggest that any veridical effects of GABA food supplements on brain and cognition might be exerted through BBB passage or, more indirectly, via an effect on the enteric nervous system. We conclude that the mechanism of action of GABA food supplements is far from clear, and that further work is needed to establish the behavioral effects of GABA.

Indexed as

blood–brain barriercognitionenteric nervous systemfood supplementsGABA

Identifiers

PMID26500584
PMCPMC4594160
OpenAlexW2109086173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.